Meet the Start-ups

Ronald Vos | CEO | CC Diagnostics

I am Ronald Vos, CEO of CC Diagnostics, where we focus on advancing early cancer detection through innovative diagnostic solutions. With a strong background in business development and strategic leadership, have worked with industry leaders like Millipore, Thermo Fisher, and Luminex, gaining valuable experience in bringing groundbreaking technologies to market. At CC Diagnostics, I am committed to driving innovation and building strategic partnerships that enhance the accessibility and accuracy of cancer diagnostics. Our mission is to transform early detection, ultimately improving patient outcomes and shaping the future of healthcare.

CC Diagnostics

CC Diagnostics (Groningen, 2016) offers a clinically validated laboratory test, significantly improving cervical cancer detection rates to 97% (vs current market benchmark of 76%). Our product offers a 6x reduction in time per test for the diagnostic labs, dramatically reducing costs and improving efficiency. Our Methica test technology supports participation in screening programs from home (with self-sampled material), unlocking a broader €5.5Bn screening market worldwide. We achieved strong commercial progress, with the first 2 international orders from leading labs in the US and UK.

Total funding: €2.6M (incl. €1.2M non-dilutive). We are raising a seed round of €1M to expand commercial and R&D efforts, with €575K committed by existing and new investors.